Kiniksa Pharmaceuticals

1 follower

Kiniksa is a publicly traded biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.






Org chart

Sanj K. Patel
CEO & Chairman

Sanj K. Patel

Carsten Boess
EVP Corporate Affairs
Dana Martin
SVP Global Medical Affairs
Eben Tessari
Chief Business Officer
Martina Struck
SVP, Regulatory Affairs
Mike Megna
VP Finance & Chief Accounting Officer
Rasmus Holm-Jorgensen
Chief Strategy & Portfolio Officer
Tom Beetham
EVP Corporate Development & Operations, Chief Legal Officer
Mark Ragosa
Chief Financial Officer
Aaron Young
Senior Vice President, Chief Intellectual Property Officer
Chad Morin
Senior Vice President, Chief Compliance Officer
Ross Moat
Svp, Chief Commercial Officer
John McKenna
Group Vice President, Sales & Marketing
Joseph J. Pirrello III
Chief Business Officer
Bernie Kalmbach
Vice President Information Technology
Michael Megna
Group Vp, Finance And Chief Accounting Officer
Kelsey Brown
Director Of Program & Alliance Management
Janice Stroughter
Director Of Operations, Patient Access And Support At Kiniksa Pharmaceuticals
Jennifer Ring
Vice President, Program And Alliance Management
Mba/Ms Meryll Pray
Director, Program & Alliance Management
Ajit D'Souza Ph.D.
Senior Director, Drug (combination) Product Development & Manufacturing
David Hile
Executive Director, Drug Product Development And Manufacturing
Paul Roussel
Senior Director-combination Products